FDA withdraws accelerated approval of selinexor in DLBCL
Selinexor was originally granted accelerated approval for this indication on June 22, 2020. The withdrawal does not affect the other approved indications for
Lymphoma
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Trending now
Lymphoma
Aggressive B-Cell Lymphomas
News
Global trial gaps in representation complicate US drug approvals
As experience with the lymphoma drug glofitamab shows, global oncology trials sometimes fall short on representation of US patients and ethnic diversity. Raising
Ambassador Program
News
Society Updates
13th annual SOHO Türkiye meeting to be held April 24–26, 2026
The 13th annual SOHO Türkiye meeting to be held at the Crowne Plaza Istanbul Asia on April 24–26.
Cellular Therapy
Leukemia
Chronic Lymphocytic Leukemia
News
Sustaining momentum in R/R CLL/SLL care: a five-month follow-up
This report authored by Karine Cohen-Solal, PhD, provides a five-month snapshot of the continuous learning collaborative in relapsed or refractory in chronic leukocytic
News
Society Updates
How to muddle through the less good times? Practice aequanimitas
Thanks to the many happy choices I have made over the years, my personal and professional lives are full and busy in 2025.
Lymphoma News
SOHO 2025
Meetings / Conferences
News
Today’s Next Questions session explores the “shift” in treatment for Hodgkin lymphoma
This talk will explore the rationale behind the use of checkpoint blockade as part of upfront therapy and put these recent results into
SOHO 2025
Meetings / Conferences
News
A collaborative approach will advance the field and SOHO’s mission
I am honored to step into the role as Deputy Director for the Society of Hematologic Oncology (SOHO). Having collaborated with the SOHO
SponsoredContent
Lymphoma
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Muhammad Bilal Abid, MD, MS, on protecting patients with blood cancers from COVID-19
Dr. Abid, a clinician-scientist at the University of Texas Health Science Center in Houston, outlined the heightened risks COVID-19 poses for immunocompromised patients
Leukemia
Acute Lymphoblastic Leukemia
The future of leukemia care requires investing in people, not just science
Dr. Jabbour writes about why the future of leukemia care requires investing in people, and a fundraising initiative to help students caught in
SOHO Insider Podcast
For CML, the science is here now access must follow
Jerald Radich, MD, of Fred Hutchinson Cancer Center in Seattle, sits down with Saad Usmani, MD, of Memorial Sloan Kettering Cancer Center in